Application Deadline Draws Near for 1999 Charles E. Culpeper Foundation Scholarships in Medical Science

Publication
Article
OncologyONCOLOGY Vol 12 No 6
Volume 12
Issue 6

The Charles E. Culpeper Foundation is currently accepting applications for its 1999 Scholarships in Medical Science Program, designed to support the career development of academic physicians

The Charles E. Culpeper Foundation is currently accepting applications for its 1999 Scholarships in Medical Science Program, designed to support the career development of academic physicians.

Up to four awards of $100,000 per year for 3 years will be made to United States medical schools on behalf of candidates who are US citizens or aliens who have been granted permanent US residence (proof required), have received their md degree from a US medical school in 1990 or later (except under extraordinary circumstances), and are judged worthy of support by virtue of the quality of their research proposals. All scientific research relevant to human health is eligible for consideration. No institution may nominate more than one candidate.

In selecting awardees, emphasis will be on identifying young physicians with clear potential for making substantial contributions to science as academic physicians. Since January 1988, 33 physicians have been selected as Charles E. Culpeper Foundation Medical Scholars.

The deadline for applications is August 14, 1998. Awards will be announced in January 1999, for activation on or about July 1, 1999. Application forms and instructions may be obtained on the Web at www.culpeper.org or by contacting the Charles E. Culpeper Foundation at Financial Centre, 695 East Main Street, Stanford, CT 06901-2155 (telephone: 203-975-1240; fax phone: 203-975-1847).

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content